176
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Low prevalence of hepatitis E in Iceland: a seroepidemiological study

, , &
Pages 293-296 | Received 20 Sep 2017, Accepted 18 Dec 2017, Published online: 08 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

H. K. Björnsson, A. Sverrisdottir & E. S. Björnsson. (2022) Dili is rare amongst patients without liver metastases receiving cancer treatment in Iceland: a population-based cohort study. Scandinavian Journal of Gastroenterology 57:7, pages 856-861.
Read now

Articles from other publishers (10)

Rei Hirano, Tatsuo Kanda, Masayuki Honda, Shuhei Arima, Mai Totsuka, Ryota Masuzaki, Shini Kanezawa, Reina Sasaki-Tanaka, Naoki Matsumoto, Hiroaki Yamagami, Tomotaka Ishii, Masahiro Ogawa, Shuzo Nomura, Mariko Fujisawa, Kei Saito, Masaharu Takahashi, Hiroaki Okamoto & Hirofumi Kogure. (2023) Hepatitis E Virus Infection Caused Elevation of Alanine Aminotransferase Levels in a Patient with Chronic Hepatitis B and Choledocholithiasis. Reports 6:4, pages 55.
Crossref
Robert John Fontana, Ronald E. Engle, Paul H. Hayashi, Jiezhun Gu, David E. Kleiner, Hahn Nguyen, Huiman Barnhart, Jay H. Hoofnagle & Patrizia Farci. (2022) Incidence of Hepatitis E Infection in American Patients With Suspected Drug-Induced Liver Injury Is Low and Declining: The DILIN Prospective Study. American Journal of Gastroenterology 117:9, pages 1462-1470.
Crossref
Helgi Kristinn Björnsson, Bjorn Gudbjornsson & Einar Stefan Björnsson. (2022) Infliximab-induced liver injury: Clinical phenotypes, autoimmunity and the role of corticosteroid treatment. Journal of Hepatology 76:1, pages 86-92.
Crossref
Helgi K. Björnsson, Einar S. Björnsson, Bharathi Avula, Ikhlas A. Khan, Jon G. Jonasson, Marwan Ghabril, Paul H. Hayashi & Victor Navarro. (2020) Ashwagandha as a cause for liver injury. Liver International 40:8, pages 2035-2036.
Crossref
Helgi K. Björnsson, Einar S. Björnsson, Bharathi Avula, Ikhlas A. Khan, Jon G. Jonasson, Marwan Ghabril, Paul H. Hayashi & Victor Navarro. (2020) Ashwagandha‐induced liver injury: A case series from Iceland and the US Drug‐Induced Liver Injury Network. Liver International 40:4, pages 825-829.
Crossref
Barbara Wilhelm, Lisa Waddell, Judy Greig & Ian Young. (2019) Systematic review and meta-analysis of the seroprevalence of hepatitis E virus in the general population across non-endemic countries. PLOS ONE 14:6, pages e0216826.
Crossref
Nicoletta Vonesch, Alessandra Binazzi, Michela Bonafede, Paola Melis, Anna Ruggieri, Sergio Iavicoli & Paola Tomao. (2019) Emerging zoonotic viral infections of occupational health importance. Pathogens and Disease 77:2.
Crossref
R. Bassal, M. Wax, R. Shirazi, T. Shohat, D. Cohen, D. David, S. Abu-Mouch, Y. Abu-Ghanem, E. Mendelson, Z. Ben-Ari & O. Mor. (2019) Seroprevalence of hepatitis E virus in dromedary camels, Bedouins, Muslim Arabs and Jews in Israel, 2009–2017. Epidemiology and Infection 147.
Crossref
Xiangyuan Huang, Yu Huang, Abram L. Wagner, Xiangxiang Chen & Yihan Lu. (2018) Hepatitis E virus infection in swine workers: A meta‐analysis. Zoonoses and Public Health.
Crossref
Johannes Horn, Mahrrouz Hoodgarzadeh, Carolina J. Klett-Tammen, Rafael T. Mikolajczyk, Gérard Krause & Jördis J. Ott. (2018) Epidemiologic estimates of hepatitis E virus infection in European countries. Journal of Infection 77:6, pages 544-552.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.